The drug has been approved for the treatment of adult patients with complicated urinary tract infections (cUTI), including ...
Wockhardt shares rose 18.33% intraday to a record high of Rs 2096.45. Market cap of the firm stood at Rs 33,732 crore.
Wockhardt receives CDSCO approval for Zaynich (Zidebactam/Cefepime) antibiotic for complicated urinary tract infections in ...
Urinary tract infections (UTIs) are a severe public health problem that are caused by a range of different pathogens. When the infection migrates to the upper urinary tract or is seeded there via ...
Press Trust of India on MSN
Wockhardt gets regulatory nod to market UTI drug in India
New Delhi, May 28 (PTI) Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control ...
New Delhi, May 28 (PTI) Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for import and marketing of its indigenously discovered and ...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, May 28, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: ...
Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to market its newly developed antibiotic, Zaynich, in India.The ...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, May 28, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting ...
Special to The Tribune ...
Stocks like Physicswallah, Ashok Leyland, Deepak Fertilisers & Petrochemicals Corporation, Bata India, PC Jeweller, GMR ...
AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results